Searched for
INDIA PHARMACEUTICAL MARKET GROWTH
Need one or two Indian pharma firms to be among global top 5: PM ModiPrime Minister Modi urged Indian pharmaceutical companies to reach global top five. The Indian pharma industry ranks third globally by volu...- India-UAE Business Expansion Forum: The next growth frontier for Indian SMEsAs Indian businesses look beyond exports towards building a lasting international presence, the India-UAE Business Expansion Forum will exp...
- Gland Pharma appoints Dr Reddy’s senior executive Deepak Sapra as CEOGland Pharma has appointed Deepak Sapra as its new chief executive officer, with his tenure set to begin on November 16, 2026, subject to h...
- Smaller FMCG brands struggle to expand consumer reachIndia’s FMCG market is becoming more difficult for smaller brands, with only 56% of low-penetration brands growing their consumer reach in ...
- Govt tightens drug quality net, initiates 950 actions since 2022: Over 1,100 cough syrup makers facing intensive audits amid quality concernsThe government has initiated 950 enforcement actions against pharmaceutical companies since December 2022. These actions aim to improve the...
- Drug formulations & biologicals keep India's pharma exports healthy in Q1During the first quarter of fiscal 2027, India's pharmaceutical exports soared to $8.10 billion, showcasing remarkable strength in drug for...
- Nutraceuticals, get it right from the startThe Indian supplements market is anticipated to soar to nearly fifty-seven billion dollars by twenty thirty, driven by heightened consumer ...
- Independence Day 2026: The Kolkata chemist who sold foreign medicines, backed Swadeshi and built a pharma empireIndependence Day 2026: Butto Kristo Paul & Co. started as a modest establishment focused on importing foreign medicines. Over time, it blos...
- India sets sail to add more trade muscle as it signs PTA terms with SACUIndia and the Southern African Customs Union signed terms to start trade negotiations. This move revives talks after previous rounds stalle...
- Marksans Pharma shares rally over 9% after Q1 profit spikes 174% YoY to Rs 159 croreMarksans Pharma shares surged after Q1FY27 profit jumped 174% YoY to Rs 159 crore. Revenue rose 35.6% to Rs 841 crore, while EBITDA hit a r...
- Critical minerals being prioritised in trade, investment engagements: Govt tells ParliamentIndia is strengthening supply chains by prioritizing energy and semiconductor sectors. The nation aims to reduce import dependence through ...
- Medical devices are not pharma products, companies say while opposing Draft BillIndia’s medical device industry and healthcare groups have opposed the draft Drugs, Medical Devices and Cosmetics Bill, 2026, arguing that ...
- India, South Africa-led SACU group may ink terms of reference for negotiating trade pact on Aug 12India and the SACU group will sign terms of reference for trade talks. Negotiations for a preferential trade agreement are expected to begi...
- Akums Drugs shares rally 9% hit 52-week high after Q1 results; stock up 67% YTDAkums Drugs shares rose sharply on Monday to hit a 52-week high after the company reported strong Q1 FY27 results. Revenue rose 13.9% year-...
- CNH's India posts 42% jump in H1 tractor sales, eyes capacity boost as US tariff strain easesIn a significant development, CNH India has witnessed a 42 percent rise in domestic tractor sales, securing its highest market share to dat...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Warburg set to buy Seacod-maker Universal NutriScience for Rs 2800 croreWill be 4th acquisition for the US private equity giant in India’s healthsector in four months. Kedaara to make 5x rupee returns on exit.
- Gland Pharma inks strategic CDMO deal with global pharma firm, eyes $90-100 million annual revenueGland Pharma has signed a strategic Manufacturing and Supply Agreement with a leading global pharmaceutical company for technology transfer...
- Emcure Pharma net profit up 36% at Rs 292 croreEmcure Pharmaceuticals reported a 23% revenue increase in the first quarter. Ebitda grew 25.8% with improved margins, reflecting productivi...
- India pharma sector to miss 2030 sales target amid tariff and shipping woes, trade body saysIndia's pharmaceutical industry is expected to reach$80-90 billion by 2030, well below its earlier$130 billion target, as U.S. tariff uncer...
Load More
